Literature DB >> 19174424

Sexually transmitted infection risk exposure among black and minority ethnic youth in northwest London: findings from a study translating a sexually transmitted infection risk-reduction intervention to the UK setting.

M Gerressu1, G Elam, R Shain, C Bonell, G Brook, J Dimmitt Champion, R French, J Elford, G Hart, J Stephenson, J Imrie.   

Abstract

OBJECTIVES: Young black women are disproportionately affected by sexually transmitted infections (STI) in the UK, but effective interventions to address this are lacking. The Young Brent Project explored the nature and context of sexual risk-taking in young people to inform the translation of an effective clinic-based STI reduction intervention (Project SAFE) from the USA to the UK.
METHODS: One-to-one in-depth interviews (n = 37) and group discussions (n = 10) were conducted among men and women aged 15-27 years from different ethnic backgrounds recruited from youth and genitourinary medicine clinic settings in Brent, London. The interviews explored the context within which STI-related risks were assessed, experienced and avoided, the skills needed to recognise risk and the barriers to behaviour change.
RESULTS: Concurrent sexual partnerships, mismatched perceptions and expectations, and barriers to condom use contributed to STI risk exposure and difficulties in implementing risk-reduction strategies. Women attempted to achieve monogamy, but experienced complex and fluid sexual relationships. Low risk awareness, flawed partner risk assessments, negative perceptions of condoms and lack of control hindered condom use. Whereas men made conscious decisions, women experienced persuasion, deceit and difficulty in requesting condom use, particularly with older partners.
CONCLUSIONS: Knowledge of STI and condom use skills is not enough to equip young people with the means to reduce STI risk. Interventions with young women need to place greater emphasis on: entering and maintaining healthy relationships; awareness of risks attached to different forms of concurrency and how concurrency arises; skills to redress power imbalances and building self-esteem.

Entities:  

Mesh:

Year:  2009        PMID: 19174424     DOI: 10.1136/sti.2008.034645

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  5 in total

1.  Sexual concurrency among young African American women.

Authors:  Drenna G Waldrop-Valverde; Teaniese L Davis; Jessica M Sales; Eve S Rose; Gina M Wingood; Ralph J DiClemente
Journal:  Psychol Health Med       Date:  2013-01-31       Impact factor: 2.423

2.  Assessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPV.

Authors:  Amy Leval; Karin Sundström; Alexander Ploner; Lisen Arnheim Dahlström; Catarina Widmark; Pär Sparén
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

3.  Ethnic variations in sexual partnerships and mixing, and their association with STI diagnosis: findings from a cross-sectional biobehavioural survey of attendees of sexual health clinics across England.

Authors:  Catherine Rh Aicken; Sonali Wayal; Paula Blomquist; Stella Fabiane; Makeda Gerressu; Gwenda Hughes; Catherine H Mercer
Journal:  Sex Transm Infect       Date:  2019-08-17       Impact factor: 3.519

4.  Understanding the burden of bacterial sexually transmitted infections and Trichomonas vaginalis among black Caribbeans in the United Kingdom: Findings from a systematic review.

Authors:  Sonali Wayal; Catherine R H Aicken; Catherine Griffiths; Paula B Blomquist; Gwenda Hughes; Catherine H Mercer
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

5.  A qualitative study of attitudes towards, typologies, and drivers of concurrent partnerships among people of black Caribbean ethnicity in England and their implications for STI prevention.

Authors:  Sonali Wayal; Makeda Gerressu; Peter Weatherburn; Victoria Gilbart; Gwenda Hughes; Catherine H Mercer
Journal:  BMC Public Health       Date:  2020-02-06       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.